title: Alterations by perfluorooctanoic acid of glycerolipid metabolism in rat liver.
abstract: The effects of perfluorooctanoic acid (PFOA) feeding on hepatic levels of glycerolipids and the underlying mechanism were investigated. Feeding of rats with 0.01% of PFOA in the diet for 1 week caused an increase in the contents of phosphatidylcholine (PtdCho), phosphatidylethanolamine (PtdEtn), phosphatidylinositol (PtdIns), phosphatidylserine (PtdSer) and triglyceride (TG), which were 2.2, 2.4, 2.4, 1.6 and 5.2 times over control, respectively, on the basis of whole liver. The activities of glycerol-3-phosphate acyltransferase, diacylglycerol kinase and PtdSer decarboxylase were significantly increased upon PFOA feeding, whereas the activities of CTP:phosphoethanolamine cytidylyltransferase and PtdEtn N-methyltransferase were decreased. On the other hand, the activity of CTP:phosphocholine cytidylyltransferase was not increased by PFOA. Upon PFOA feeding, hepatic level of 16:0-18:1 PtdCho was markedly increased and, by contrast, the levels of molecular species of PtdCho which contain 18:2 were decreased, resulting in the reduced concentration of molecular species of serum PtdCho containing 18:2. The increase in the level of hepatic 16:0-18:1 PtdCho seemed to be due to 3-fold increase in the activities of both delta9 desaturase and 1-acylglycerophosphocholine (1-acyl-GPC) acyltransferase. The mechanism by which PFOA causes the accumulation of glycerolipids in liver was discussed.
authors.affiliation: Faculty of Pharmaceutical Sciences, Josai University, Sakado, Saitama, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Kudo
authors.forename: H
authors.initials: H
authors.lastname: Mizuguchi
authors.forename: A
authors.initials: A
authors.lastname: Yamamoto
authors.forename: Y
authors.initials: Y
authors.lastname: Kawashima
mesh_terms: D000818:Animals; D002210:Caprylates / Q000008:administration & dosage / Q000494:pharmacology*; D002262:Carboxy-Lyases / Q000378:metabolism; D019852:Diacylglycerol Kinase / Q000378:metabolism; D004032:Diet; D005466:Fluorocarbons / Q000008:administration & dosage / Q000494:pharmacology*; D005992:Glycerol-3-Phosphate O-Acyltransferase / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008780:Methyltransferases / Q000378:metabolism; D009713:Nucleotidyltransferases / Q000378:metabolism; D050918:Phosphatidylethanolamine N-Methyltransferase; D010743:Phospholipids / Q000378:metabolism*; D012316:RNA Nucleotidyltransferases; D051381:Rats; D017208:Rats, Wistar; D013347:Subcellular Fractions / Q000378:metabolism; D014280:Triglycerides / Q000378:metabolism*
chemical_list: D002210:Caprylates; D005466:Fluorocarbons; D010743:Phospholipids; D014280:Triglycerides; C023036:perfluorooctanoic acid; D008780:Methyltransferases; D050918:Phosphatidylethanolamine N-Methyltransferase; D005992:Glycerol-3-Phosphate O-Acyltransferase; D019852:Diacylglycerol Kinase; D009713:Nucleotidyltransferases; D012316:RNA Nucleotidyltransferases; C020126:Ethanolamine-phosphate cytidylyltransferase; D002262:Carboxy-Lyases; C022353:phosphatidylserine decarboxylase